Jan. 15, 2025 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced preliminary ...
MBABANE – Mdzimba View Shisanyama has injected E50 000 into ambitious Premier League side Ezulwini United. This has reinforced the commitment to nurturing local talent and strengthening community ties ...
The Shiselweni Derby is rapidly cementing its status as one of the most significant fixtures in the country. The latest match drew over 1 000 attendees, generating an impressive revenue of more than ...
Average price of second-hand home rose by €50k in Dublin last year, with further increase expected
Support from readers like you keeps The Journal open. You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to ...
Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies ...
Jan. 15, 2025 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced preliminary ...
OptiNose, Inc. operates as a pharmaceutical company. The firm engages in the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback